ID: h-6b1d223140
Hypothesis
KCNQ2/3 (M-current) Channel Restoration Reactivates Theta Oscillation Dynamics
Aβ oligomers downregulate KCNQ2/3 voltage-gated potassium channels on PV interneurons via PKC-dependent phosphorylation, reducing accommodation and impairing theta-frequency resonance.
Alzheimer's disease
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 3 support✗ 2 oppose
✓ All Quality Gates Passed
🧪 Overview
Aβ oligomers downregulate KCNQ2/3 voltage-gated potassium channels on PV interneurons via PKC-dependent phosphorylation, reducing accommodation and impairing theta-frequency resonance. Pharmacological or optogenetic restoration of M-current kinetics reinstates theta rhythmicity. This hypothesis benefits from the strongest pharmacological precedent (retigabine already shown effective in Tg2576 mice) but the optogenetic ChR2-proposed component is mechanistically inelegant—sustained depolarization does not replicate M-current gating kinetics and risks depolarization block. The Domain Expert recommends prioritizing pharmacological KCNQ2/3 potentiation as the primary translational strategy while using optogenetic approaches as mechanistic probes only.
🧬 Mechanism
🔗 Mechanism from KG for KCNQ2/KCNQ3
Auto-built from this analysis's top knowledge-graph edges.
graph TD
PV_interneurons["PV_interneurons"] -->|associated with| gamma_oscillations["gamma oscillations"]
A__Oligomers["Aβ Oligomers"] -->|regulates| KCNQ2_3_channels["KCNQ2/3 channels"]
n40_Hz_stimulation["40 Hz stimulation"] -.->|inhibits| Amyloid_Beta_Accumulation["Amyloid Beta Accumulation"]
gamma_oscillations_1["gamma oscillations"] -->|regulates| Cognitive_Performance["Cognitive Performance"]
PV_protein_expression["PV protein expression"] -->|associated with| neural_activity["neural activity"]
A__1_42["Aβ 1-42"] -->|associated with| excitatory_synaptic_input["excitatory synaptic inputs to PV interneurons"]
closed_loop_theta_burst_s["closed-loop theta-burst stimulation"] -->|associated with| SYNAPTIC_PLASTICITY["SYNAPTIC_PLASTICITY"]
A__Oligomers_2["Aβ Oligomers"] -->|disrupts| theta_oscillations["theta_oscillations"]
A__Oligomers_3["Aβ Oligomers"] -.->|inhibits| gamma_oscillations_4["gamma oscillations"]
PV_interneurons_5["PV_interneurons"] -->|associated with| feedforward_inhibition["feedforward inhibition"]
theta_burst_stimulation["theta burst stimulation"] -->|targets| APP_PS1_mouse_model["APP/PS1 mouse model"]
A__Oligomers_6["Aβ Oligomers"] -.->|inhibits| KCNQ2_3_channels_7["KCNQ2/3 channels"]
style PV_interneurons fill:#4fc3f7,stroke:#333,color:#000
style gamma_oscillations fill:#4fc3f7,stroke:#333,color:#000
style A__Oligomers fill:#4fc3f7,stroke:#333,color:#000
style KCNQ2_3_channels fill:#4fc3f7,stroke:#333,color:#000
style n40_Hz_stimulation fill:#4fc3f7,stroke:#333,color:#000
style Amyloid_Beta_Accumulation fill:#4fc3f7,stroke:#333,color:#000
style gamma_oscillations_1 fill:#4fc3f7,stroke:#333,color:#000
style Cognitive_Performance fill:#4fc3f7,stroke:#333,color:#000
style PV_protein_expression fill:#4fc3f7,stroke:#333,color:#000
style neural_activity fill:#4fc3f7,stroke:#333,color:#000
style A__1_42 fill:#4fc3f7,stroke:#333,color:#000
style excitatory_synaptic_input fill:#4fc3f7,stroke:#333,color:#000
style closed_loop_theta_burst_s fill:#4fc3f7,stroke:#333,color:#000
style SYNAPTIC_PLASTICITY fill:#4fc3f7,stroke:#333,color:#000
style A__Oligomers_2 fill:#4fc3f7,stroke:#333,color:#000
style theta_oscillations fill:#4fc3f7,stroke:#333,color:#000
style A__Oligomers_3 fill:#4fc3f7,stroke:#333,color:#000
style gamma_oscillations_4 fill:#4fc3f7,stroke:#333,color:#000
style PV_interneurons_5 fill:#4fc3f7,stroke:#333,color:#000
style feedforward_inhibition fill:#4fc3f7,stroke:#333,color:#000
style theta_burst_stimulation fill:#4fc3f7,stroke:#333,color:#000
style APP_PS1_mouse_model fill:#ef5350,stroke:#333,color:#000
style A__Oligomers_6 fill:#4fc3f7,stroke:#333,color:#000
style KCNQ2_3_channels_7 fill:#4fc3f7,stroke:#333,color:#000⚖️ Evidence
⚖️ Evidence Matrix3 supports2 contradicts
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — KCNQ2
No curated PDB or AlphaFold mapping for KCNQ2 yet. Search RCSB →
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for KCNQ2.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↘
Falling
7d Momentum
▼ 1.7%
Volatility
Medium
0.0382
Events (7d)
3
Price History
▼10.4%💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF PKC inhibitor (chelerythrine, 5 mg/kg, i.p., 7 days) is co-administered with Aβ oligomers (100 nM, intracerebroventricular) to young C57BL/6 mice, THEN hippocampal theta oscillation power will rema | Theta oscillation power will be preserved at ≥85% of vehicle-control levels, with no significant change in peak theta frequency (7-9 Hz), confirming that blocki | — no observation — | pending | 0.65 |
| IF pharmacological KCNQ2/3 potentiation with retigabine (10 mg/kg, i.p., 14 days) is administered to 8-month-old Tg2576 AD mice, THEN hippocampal theta oscillation (4-12 Hz) power during active explor | Hippocampal theta oscillation power will increase from ~40% of wild-type baseline to ≥90% of wild-type baseline, as measured by in vivo LFP recordings during Y- | — no observation — | pending | 0.78 |
🔮 Falsifiable Predictions (2)
pendingconf 78%
IF pharmacological KCNQ2/3 potentiation with retigabine (10 mg/kg, i.p., 14 days) is administered to 8-month-old Tg2576 AD mice, THEN hippocampal theta oscillation (4-12 Hz) power during active exploration will be restored to age-matched wild-type baseline levels within 24 hours of final dose.
Predicted outcome: Hippocampal theta oscillation power will increase from ~40% of wild-type baseline to ≥90% of wild-type baseline, as measured by in vivo LFP recordings
Falsification: Theta oscillation power remains below 70% of wild-type baseline despite sustained retigabine treatment, indicating restoration of M-current kinetics is insufficient to reinstate theta rhythmicity in t
pendingconf 65%
IF PKC inhibitor (chelerythrine, 5 mg/kg, i.p., 7 days) is co-administered with Aβ oligomers (100 nM, intracerebroventricular) to young C57BL/6 mice, THEN hippocampal theta oscillation power will remain within 15% of vehicle-treated controls, demonstrating that PKC inhibition prevents Aβ-induced sup
Predicted outcome: Theta oscillation power will be preserved at ≥85% of vehicle-control levels, with no significant change in peak theta frequency (7-9 Hz), confirming t
Falsification: Theta oscillation power falls below 70% of vehicle-control baseline despite PKC inhibition, indicating Aβ suppresses theta rhythms through PKC-independent mechanisms or that KCNQ2/3 downregulation is
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.